Bulbitech

One device, a suite of neuro-ophthalmic tests

Our Story

Dr. Bjørn Helland-Hansen introducing Bulbitech’s technology and explaining the importance of having a suite of multiple neuro-ophthalmic tests available in daily clinical practice.

Play Video

Current Tests

Visual Field test

Visual Field test

Based on eye movement perimetry our 26-point visual field test screens the patient's visual field in 90 seconds per eye. Measuring the saccadic reaction time, an index for detection of glaucomatous visual field defects, our visual field test quantifies the reaction time towards a peripheral target and detects blind spots

Pupil test

Pupil test

Our pupil test, in four sequences of alternating black and white light patters, simultaneously quantifies both direct and consensual pupillary light reflex in order to detect Relative Afferent Pupil Defect (RAPD)

Ptosis test

Ptosis test

Ptosis is a drooping or falling of the upper eyelid and can be one of the first signs of stroke, brain tumour, cancer, neurological disorders or damage to the nerves or muscles supporting the eyelid

Saccade test

Saccade test

Performed during the visual field test our saccade test measures the peak velocity of horizontal, vertical and oblique saccades to early detect potential neurological diseases, such as Parkinson's disease, dementia or Huntington's disease

Upcoming Tests

Acuity test

Acuity test

Eye tracking based acuity testing is objective, doesn’t require operational assistance, and takes just 60 seconds

Nystagmus test

Nystagmus test

Nystagmus is a “wobbling eye” due to an involuntary eye movement. Nystagmus prevalence is estimated to be 24 persons in a 10.000 population. Currently there is no objective quantification of nystagmus

Strabismus test

Strabismus test

Eye deviations are manually assessed, and subjectively interpreted. BulbiCAM will quantify the results of horizontal and vertical eye deviations

Cover Test

Cover test

Automated eye deviation tested using eye tracking technology. Patient stimulus allows the measurement of eye positions under single and alternating cover-uncover test

Vergence Test

Vergence test

Automated smooth vergence assessment, using virtually 3D stimulus, gives quantified data for near point of convergence and recovery including near pupil reflex

Benefits of our technology

The problems we solve

Our purpose

Our goal is to provide neuro-ophthalmologists, ophthalmologists and optometrists with a neuro-ophthalmic diagnostic support device for the early detection of neuro-ophthalmic disorders, based on eye tracking technology. Our BulbiCAM offers the user multiple neuro-ophthalmic examinations of which the outcome can be assessed in our BulbiHUB software, making it possible to quickly and objectively add the neurological part of the eye examination to your diagnostic workflow. In addition results can be shared amongst clinicians through our telemedicine functionality, facilitating the patient to undergo the examination at a physical location while the neuro-ophthalmologist is working remotely. Ultimately our BulbiCAM requires the patient to do the work, can be operated by anyone and generates objective clinical results needed to fully assess the patient’s neuro-ophthalmic condition.

Early detection of neuro-ophthalmic disorders with a dedicated diagnostic device that reduces patient chair time

Decentralizing access to neuro-ophthalmic examinations providing remote accessibility to patient's test results for neuro-ophthalmic specialists

Supporting already understaffed eye care professionals to face an increase demand of eye care by providing them a neuro-ophthalmic diagnostic support device in which the patient does the work and can be operated by anyone

Generating objective clinical results, reducing manually performed neuro-ophthalmic examinations

BulbiCAM

One neuro-ocular diagnostic device offering multiple examinations

More information is coming soon. To stay updated please register your interest and subscribe to our newsletter

Our solution

BulbiHUB software

Software enables users to assess clinical outcome of all eye examination tests conducted with our BulbiCAM. Furthermore it is able to process clinical outcome from eye examinations conducted with third party ophthalmic devices resulting in one unique clinical dashboard overview of clinical test results

Telemedicine

Data can be shared, tele ophthalmology consultations with patients are possible and third-party devices can be integrated, resulting in a clinical workflow that can continue remotely during pandemic outbreaks

AI [Artificial Intelligence]

Algorithms can be developed to detect early stage neuro- ocular dysfunctions and analyze our collected “big data” in order to become the first company that generates AI analysis on eye tracking data

Our company

Our Timeline

2015
Funding from public funds and private investors for technology development

2016
Technical R&D development on eye tracking
2017
Company & software CE-marks based on QMS
2018
Funding from public funds and private investors to complete smaller prototype

2019
Finalist in the DNB Healthcare prize

2020
Bulbitech wins healthcare pitching contest at Oslo Innovation Week
Frozen BulbiCAM prototypes for clinical testing

Our team

Board

ODD HJELMELAND

Executive Chairman

TOR ULLEBERG

Executive Board Member

KENT THOMAS HÅGENSTAD RANUM

Executive Board Member

HARALD FREDRIK ULLTVEIT-MOE

Ophthalmologist

Management team

BÅRD DALHØI

CSO
bard@bulbitech.com

HANS-PETER KURZ

CTO
hape@bulbitech.com

DENNIS HENS

CEO
dennis@bulbitech.com

BJØRN A. HELLAND-HANSEN, MD

CMO
bjorn@bulbitech.com

ATLE MAGNUS ØVREBUST

CFO
atle@bulbitech.com

Clinical Advisory Board

KLAUS A. SJØHAUG

Optometrist/Doctor of Optometry

JOHAN PEL

Associate Professor Neuroscience

HANS VAN DER STEEN

Professor Neuroscience

STIG LARSEN

Professor Controlled Clinical Research Methodology and Statistics

Partners

Please subscribe to our newsletters